There were 260 press releases posted in the last 24 hours and 199,951 in the last 365 days.

Agave Dream Recalls Cappuccino Ice Cream Because of Possible Health Risk

Agave Dream of Palos Verdes Peninsula, CA is recalling 389 cases Cappuccino Ice Cream because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Although healthy individuals may suffer only short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain and diarrhea, Listeria infection can cause miscarriages and stillbirths among pregnant women.

Product was distributed across the United States through retail stores receiving product from KeHE Romeoville, Illinois warehouse, DPI NW, Americold L.A., IWI Franklin Indiana warehouse, Haddon House Richburg, SC.

Recalled product is Agave Dream Cappuccino ice cream pints packed in a brown paper pint size container with “Agave Dream” printed front of carton with Best By date 07/04/17, UPC 899349002048.

No illnesses have been reported to date.

The recall is the result of a routine sampling by the state of WA which revealed that the finished products contained the bacteria. The company has ceased the production and distribution of the product as FDA and the company continue their investigation as to what caused the problem.

Consumers who have purchased Agave Dream Cappuccino ice cream with “Best By” date 07/04/17 are urged to return it to the place of purchase for a full refund. Consumers with questions may contact the company at 866-993-4438 or agavedream@sbcglobal.net. Monday – Saturday, 9am PST – 5pm PST.

###

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.